HEALTH

ALLEGAN, Mich. — Perrigo on Monday announced that it received final approval from the Food and Drug Administration for its store-brand version of Mucinex tablets.

Perrigo is still in litigation with Reckitt Benckiser involving the introduction of a private-label Mucinex. "Perrigo is working through the litigation and expects to begin shipping this product in our retail and wholesale customers' store brand packaging in the second half of our fiscal year," Perrigo chairman and CEO Joseph Papa said.

SILVER SPRING, Md. — The Food and Drug Administration last week took legal action against the dietary supplement manufacturer ATF Fitness Products for substituting ingredients and products without noting the changes on the final product labels.

The permanent injunction, filed on behalf of the FDA by the U.S. Department of Justice, would stop the defendants from making and distributing more than 400 products for being in violation of the Federal Food, Drug and Cosmetic Act. Brands include Sci-Fit, Nature's Science and For Store Only.

There’s been discussion for years about the “moment of truth” and whether the ultimate — and final — purchase decision is made at the shelf. Shopper behavior in a store has been studied, analyzed, hypothesized and debated. Some would argue there is too much stimuli at the shelf, others not enough. Some may suggest that retail pricing is the key deciding factor. Perhaps it’s category assortment, in-stock condition or shelf-edge signage. Still others suggest competitive positioning is the key determinant.

COLUMBIA, Mo. — A new tool developed by researchers at the University of Missouri improved both the efficiency and accuracy of acquiring data needed for high-quality diabetes care, according to a new study.

WAUKESHA, Wis. — Hamacher Resource Group will be participating in The Drug Store News Group's Diabetes Leadership Forum, part of the Industry Issues conference, to be held Nov. 29 at the New York Athletic Club. HRG VP Dave Wendland will moderate the discussion for the eighth year in a row. The panel will include six of the leading health and beauty retailers in the country.

NEW YORK — A test commonly used to identify patients with diabetes or those at risk of developing the condition may not produce accurate results among children, according to a new study conducted by researchers at the University of Michigan.

The study, published online ahead of print in the journal Diabetes Care, tested 254 overweight children using both fasting and nonfasting methods. Researchers found that the recommended test, hemoglobin A1C (HbA1C), missed more cases of prediabetes or diabetes, compared with other tests.

SIOUX FALLS, S.D. — PharmaCline has launched a topical antibiotic for prediabetes and diabetes patients that is designed to treat minor cuts, scrapes and burns.

Diabecline, the company said, is an over-the-counter antibiotic that targets the source of infection through site-specific penetration technology.

"Our Diabecline antibiotic allows users who are at greater risk of developing serious infections to achieve better care," PharmaCline CEO Steve Keough said.

CAMBRIDGE, Mass. — An online data sharing platform announced it will debut a daily blood-glucose monitoring feature for its more than 2,000 diabetes patients.

PatientsLikeMe said patients will be able to report daily glucose levels, as well as continue sharing and learning from HbA1C scores, treatments and dosages, in addition to symptoms and severity.

The feature will be launched in early December, PatientsLikeMe said.